Integrated Filing — IndAS

General information about company
Scrip Code	500477
NSE Symbol	ASHOKLEY
MSEI Symbol	NOTLISTED
ISIN	INE208A01029
Name of company	Ashok Leyland Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	23-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	08-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Commercial Vehicle
Start date and time of board meeting	23-May-2025   13:00:00
End date and time of board meeting	23-May-2025   14:55:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	No
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	Yes
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?	Yes
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-12
Indicate Company website link for updated RPT policy of the Company	https://www.ashokleyland.com/backend/wp-content/uploads/2024/04/Policy-on-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
No default, hence Not Applicable.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	119067100000	387527400000
	Other income	1059300000	2502500000
	Total income	120126400000	390029900000
2	Expenses
(a)	Cost of materials consumed	73720000000	257117400000
(b)	Purchases of stock-in-trade	4633800000	16804600000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	5674400000	2305800000
(d)	Employee benefit expense	6514900000	24062700000
(e)	Finance costs	471200000	2169100000
(f)	Depreciation, depletion and amortisation expense	1788500000	7193400000
(f)	Other Expenses
1	Other Expenses	10614400000	37931300000
	Total other expenses	10614400000	37931300000
	Total expenses	103417200000	347584300000
3	Total profit before exceptional items and tax	16709200000	42445600000
4	Exceptional items	-136500000	1037300000
5	Total profit before tax	16572700000	43482900000
6	Tax expense
7	Current tax	5845800000	14974000000
8	Deferred tax	-1731800000	-4524000000
9	Total tax expenses	4114000000	10450000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	12458700000	33032900000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	12458700000	33032900000
17	Other comprehensive income net of taxes	57500000	-119600000
18	Total Comprehensive Income for the period	12516200000	32913300000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	2936500000	2936500000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		112251400000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	4.24	11.25
	Diluted earnings (loss) per share from continuing operations	4.24	11.23
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	4.24	11.25
	Diluted earnings (loss) per share from continuing and discontinued operations	4.24	11.23
24	Debt equity ratio	0.0013	0.0013
25	Debt service coverage ratio	0.0822	0.0451
26	Interest service coverage ratio	0.5745	0.3495
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	46819700000
	Capital work-in-progress	2768700000
	Investment property
	Goodwill	4499000000
	Other intangible assets	7136200000
	Intangible assets under development	1478900000
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	56542600000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	5750100000
	Total non-current financial assets	62292700000
	Deferred tax assets (net)	343200000
	Other non-current assets	6596900000
	Total non-current assets	131935300000
2	Current assets
	Inventories	29573200000
	Current financial asset
	Current investments	30187000000
	Trade receivables, current	28873200000
	Cash and cash equivalents	26598200000
	Bank balance other than cash and cash equivalents	461300000
	Loans, current	0
	Other current financial assets	1182100000
	Total current financial assets	87301800000
	Current tax assets (net)	0
	Other current assets	6211200000
	Total current assets	123086200000
3	Non-current assets classified as held for sale	236800000
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	255258300000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	2936500000
	Other equity	112251400000
	Total equity attributable to owners of parent	115187900000
	Non controlling interest
	Total equity	115187900000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	9339700000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	125700000
	Total non-current financial liabilities	9465400000
	Provisions, non-current	7089700000
	Deferred tax liabilities (net)	5478900000
	Deferred government grants, Non-current
	Other non-current liabilities	3728600000
	Total non-current liabilities	25762600000
	Current liabilities
	Current financial liabilities
	Borrowings, current	5477500000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	565800000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	72481100000
	Total Trade payable	73046900000
	Other current financial liabilities	12112200000
	Total current financial liabilities	90636600000
	Other current liabilities	9156300000
	Provisions, current	8251500000
	Current tax liabilities (Net)	6216900000
	Deferred government grants, Current
	Total current liabilities	114261300000
3	Liabilities directly associated with assets in disposal group classified as held for sale	46500000
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	140070400000
	Total equity and liabilites	255258300000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit and loss	94500000	-78000000
	Total Amount of items that will not be reclassified to profit and loss	94500000	-78000000
2	Income tax relating to items that will not be reclassified to profit or loss	23800000	-19600000
3	Amount of items that will be reclassified to profit and loss
1	Items that will be reclassified to profit and loss	-17600000	-81800000
	Total Amount of items that will be reclassified to profit and loss	-17600000	-81800000
4	Income tax relating to items that will be reclassified to profit or loss	-4400000	-20600000
5	Total Other comprehensive income	57500000	-119600000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			43482900000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			2169100000
	Adjustments for decrease (increase) in inventories			2333700000
	Adjustments for decrease (increase) in trade receivables, current			6539500000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			1869600000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			14245200000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			10027700000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			509200000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			7193400000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			242600000
	Adjustments for provisions, current			630400000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			1417700000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-27000000
	Adjustments for dividend income			485400000
	Adjustments for interest income			402700000
	Adjustments for share-based payments			27100000
	Adjustments for fair value losses (gains)			-1504900000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-636400000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-30200000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			44118600000
	Net cash flows from (used in) operations			87601500000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			9407300000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			78194200000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			7170600000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			299800000
	Purchase of property, plant and equipment			9542900000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			13300000000
	Cash receipts from repayment of advances and loans made to other parties			15250000000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			485400000
	Interest received			394700000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-27195000000
	Net cash flows from (used in) investing activities	-40778600000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			16700000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			49420200000
	Repayments of borrowings			57180300000
	Payments of lease liabilities			593300000
	Dividends paid			20407700000
	Interest paid			1490600000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-30235000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			7180600000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			-1100000
	Net increase (decrease) in cash and cash equivalents			7179500000
	Cash and cash equivalents cash flow statement at beginning of period			19418700000
	Cash and cash equivalents cash flow statement at end of period			26598200000